The First and Only Anti-Amyloid Therapy in China that Enables At-Home Administration for Alzheimer’s Disease, a Progressive Neurodegenerative Disease The First and Only Anti-Amyloid Therapy in China that Enables At-Home Administration for Alzheimer’s Disease, a Progressive Neurodegenerative Disease
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of UWM Holdings Corporation (NYSE: UWMC) between March 9, 2026 and August 5, 2026, inclusive (the “Class Period”), of the important October 13, 2026 lead plaintiff deadline.
Related Bing News Results Globe Newswire, World News and Updates | National Post Thu, 27 Aug 2026 15:39:00 GMT Intelligence naming the individuals behind the aliases, and mapping the infrastructure and victims, went to the Australian Federal Police (AFP) and Western Australia Police Force (WAPF) and the ...